Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Large-scale testing (Phase 3)Temporarily pausedNCT00002362
What this trial is testing

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00002416
What this trial is testing

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 390
Not applicableStudy completedNCT00002387
What this trial is testing

The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 80
Post-approval studies (Phase 4)Study completedNCT00002179
What this trial is testing

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 200
Not applicableStudy completedNCT00000861
What this trial is testing

The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,900
Early research (Phase 1)Study completedNCT00000902
What this trial is testing

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 217
Testing effectiveness (Phase 2)Study completedNCT00006144
What this trial is testing

HIV-Disease Development in Aging

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT00002230
What this trial is testing

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Who this might be right for
HIV Infections
Northwestern University 100
Early research (Phase 1)Study completedNCT00002381
What this trial is testing

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine

Who this might be right for
HIV Infections
Boehringer Ingelheim 24
Large-scale testing (Phase 3)Study completedNCT00008528
What this trial is testing

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 525
Early research (Phase 1)Study completedNCT00002422
What this trial is testing

A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy

Who this might be right for
HIV Infections
Harbor Therapeutics 42
Testing effectiveness (Phase 2)Study completedNCT00000872
What this trial is testing

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Post-approval studies (Phase 4)Study completedNCT00002229
What this trial is testing

Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 80
Early research (Phase 1)Study completedNCT00002183
What this trial is testing

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 60
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Not applicableStudy completedNCT00006617
What this trial is testing

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Study completedNCT00000949
What this trial is testing

Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 460
Testing effectiveness (Phase 2)Study completedNCT00001067
What this trial is testing

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableWithdrawnNCT00051090
What this trial is testing

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00006279
What this trial is testing

The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation